Adopting the new eGFR Calculator to Limit Transplant Candidate Racial Disadvantage
Wednesday, December 8, 2021 - 14:00 to 15:00
After participating in this webinar, the attendee will be able to:
- Review racial inequities in access to pre-emptive waitlisting and kidney transplantation that are enabled by flawed features of the US allocation system.
- Review results of survey on opinions of transplant clinicians on use of race in estimating GFR (conducted by AST's Kidney Pancreas Community of Practice Public Policy Work Group).
- Review final recommendations from the American Society of Nephrology (ASN) & National Kidney Foundation (NKF) Task Force to understand: a) Relevance in today’s practice, and b) Trials and tribulations
Speakers:
- Peter Reese, MD, MSCE, FAST • Professor of Medicine and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
- Mona Doshi, MBBS • Clinical Professor, University of Michigan, Ann Arbor, MI
Moderator:
- Silas Norman, MD • Clinical Associate Professor, University of Michigan, Ann Arbor, MI
Discussants:
- Matthew Cooper MD • Director, Kidney and Pancreas Transplantation, MedStar Georgetown Transplant Institute, Washington, DC
- Benjamin Hippen, MD, FAST • Senior Vice President, Head of Transplant Medicine, Fresenius Medical Care, Charlotte, NC
AST would like to thank the Transplant Diagnostics Community of Practice (TxDx COP) and Kidney Pancreas Community of Practice (KPCOP) for recommending this topic to include as part of the T3 webinar series. Learn more about AST's COPs at www.myast.org/cops.
Education Category:
Series category:
T3: Timely Topics in Transplantion